Literature DB >> 23730984

Treatment of hypertension among African Americans: the Jackson Heart Study.

Jane Harman1, Evelyn R Walker, Vicki Charbonneau, Ermeg L Akylbekova, Cheryl Nelson, Sharon B Wyatt.   

Abstract

Hypertension treatment regimens used by African American adults in the Jackson Heart Study were evaluated at the first two clinical examinations (2415 treated hypertensive persons at examination I [exam I], 2000-2004; 2577 at examination II [exam II], 2005-2008). Blood pressure (BP) was below 140/90 mm Hg for 66% and 70% of treated participants at exam I and exam II, respectively. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure treatment targets were met for 56% and 61% at exam I and exam II, respectively. Persons with diabetes or chronic kidney disease were less likely to have BP at target, as were men compared with women. Thiazide diuretics were the most commonly used antihypertensive medication, and persons taking a thiazide were more likely to have their BP controlled than persons not taking them; thiazides were used significantly less among men than women. Although calcium channel blockers are often considered to be effective monotherapy for African Americans, persons using calcium channel blocker monotherapy were significantly less likely to be at target BP than persons using thiazide monotherapy.
© 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23730984      PMCID: PMC3683967          DOI: 10.1111/jch.12088

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  34 in total

1.  Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks.

Authors:  Janice G Douglas; George L Bakris; Murray Epstein; Keith C Ferdinand; Carlos Ferrario; John M Flack; Kenneth A Jamerson; Wendell E Jones; Julian Haywood; Randall Maxey; Elizabeth O Ofili; Elijah Saunders; Ernesto L Schiffrin; Domenic A Sica; James R Sowers; Donald G Vidt
Journal:  Arch Intern Med       Date:  2003-03-10

2.  Recruiting African-American research participation in the Jackson Heart Study: methods, response rates, and sample description.

Authors:  Sonja R Fuqua; Sharon B Wyatt; Michael E Andrew; Daniel F Sarpong; Frances R Henderson; Margie F Cunningham; Herman A Taylor
Journal:  Ethn Dis       Date:  2005       Impact factor: 1.847

3.  A comparison of the efficacy and safety of a beta-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks.

Authors:  E Saunders; M R Weir; B W Kong; J Hollifield; J Gray; V Vertes; J R Sowers; M B Zemel; C Curry; J Schoenberger
Journal:  Arch Intern Med       Date:  1990-08

4.  Diuretic use in black patients with uncontrolled hypertension.

Authors:  Linda M Gerber; Samuel J Mann; Margaret V McDonald; Ya-Lin Chiu; Sridevi Sridharan; Penny H Feldman
Journal:  Am J Hypertens       Date:  2012-12-28       Impact factor: 2.689

5.  Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

Authors:  Barry R Davis; Linda B Piller; Jeffrey A Cutler; Curt Furberg; Kay Dunn; Stanley Franklin; David Goff; Frans Leenen; Syed Mohiuddin; Vasilios Papademetriou; Michael Proschan; Allan Ellsworth; John Golden; Pedro Colon; Richard Crow
Journal:  Circulation       Date:  2006-05-01       Impact factor: 29.690

6.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

7.  Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.

Authors:  Bruce M Psaty; Thomas Lumley; Curt D Furberg; Gina Schellenbaum; Marco Pahor; Michael H Alderman; Noel S Weiss
Journal:  JAMA       Date:  2003-05-21       Impact factor: 56.272

Review 8.  Improving compliance and increasing control of hypertension: needs of special hypertensive populations.

Authors:  L T Clark
Journal:  Am Heart J       Date:  1991-02       Impact factor: 4.749

9.  Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

Authors:  B J Materson; D J Reda; W C Cushman; B M Massie; E D Freis; M S Kochar; R J Hamburger; C Fye; R Lakshman; J Gottdiener
Journal:  N Engl J Med       Date:  1993-04-01       Impact factor: 91.245

Review 10.  Hypertension-related morbidity and mortality in African Americans--why we need to do better.

Authors:  Keith C Ferdinand; Elijah Saunders
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-01       Impact factor: 3.738

View more
  13 in total

1.  Gender, race, age, and regional differences in the association of pulse pressure with atrial fibrillation: the Reasons for Geographic and Racial Differences in Stroke study.

Authors:  Lama Ghazi; Monika M Safford; Yulia Khodneva; Wesley T O'Neal; Elsayed Z Soliman; Stephen P Glasser
Journal:  J Am Soc Hypertens       Date:  2016-06-07

2.  Serum potassium is a predictor of incident diabetes in African Americans with normal aldosterone: the Jackson Heart Study.

Authors:  Ranee Chatterjee; Clemontina A Davenport; Laura P Svetkey; Bryan C Batch; Pao-Hwa Lin; Vasan S Ramachandran; Ervin R Fox; Jane Harman; Hsin-Chieh Yeh; Elizabeth Selvin; Adolfo Correa; Kenneth Butler; David Edelman
Journal:  Am J Clin Nutr       Date:  2016-12-14       Impact factor: 7.045

3.  Big heart data: advancing health informatics through data sharing in cardiovascular imaging.

Authors:  Avan Suinesiaputra; Pau Medrano-Gracia; Brett R Cowan; Alistair A Young
Journal:  IEEE J Biomed Health Inform       Date:  2014-11-14       Impact factor: 5.772

4.  The High Blood Pressure-Malaria Protection Hypothesis.

Authors:  Julio Gallego-Delgado; Thomas Walther; Ana Rodriguez
Journal:  Circ Res       Date:  2016-09-22       Impact factor: 17.367

Review 5.  Challenges of cardiac image analysis in large-scale population-based studies.

Authors:  Pau Medrano-Gracia; Brett R Cowan; Avan Suinesiaputra; Alistair A Young
Journal:  Curr Cardiol Rep       Date:  2015-03       Impact factor: 2.931

6.  Obesity and synergistic risk factors for chronic kidney disease in African American adults: the Jackson Heart Study.

Authors:  Robert E Olivo; Clemontina A Davenport; Clarissa J Diamantidis; Nrupen A Bhavsar; Crystal C Tyson; Rasheeda Hall; Aurelian Bidulescu; Bessie Young; Stanford E Mwasongwe; Jane Pendergast; L Ebony Boulware; Julia J Scialla
Journal:  Nephrol Dial Transplant       Date:  2018-06-01       Impact factor: 5.992

7.  Dietary Phosphorus and Ambulatory Blood Pressure in African Americans: The Jackson Heart Study.

Authors:  Robert E Olivo; Sarah L Hale; Clarissa J Diamantidis; Nrupen A Bhavsar; Crystal C Tyson; Katherine L Tucker; Teresa C Carithers; Bryan Kestenbaum; Paul Muntner; Rikki M Tanner; John N Booth; Stanford E Mwasongwe; Jane Pendergast; L Ebony Boulware; Julia J Scialla
Journal:  Am J Hypertens       Date:  2019-01-01       Impact factor: 2.689

8.  Improving approaches to hypertension treatment in African Americans: lessons learned from the Jackson Heart Study.

Authors:  Keith C Ferdinand
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-04-29       Impact factor: 3.738

9.  The evolving clinical management of hypertension.

Authors:  Michael A Weber
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-11-10       Impact factor: 3.738

10.  The association between individual and combined components of metabolic syndrome and chronic kidney disease among African Americans: the Jackson Heart Study.

Authors:  Vincent L Mendy; Mario J Azevedo; Daniel F Sarpong; Sylvia E Rosas; Olugbemiga T Ekundayo; Jung Hye Sung; Azad R Bhuiyan; Brenda C Jenkins; Clifton Addison
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.